APP
AGIO icon

Avantax Planning Partners’s Agios Pharmaceuticals AGIO Stock Holding History

Avantax Planning Partners’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-14
Closed -$1K – 264
2018
Q1 		$1K Buy
+14
New +$1.08K ﹤0.01% 1670

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Avantax Planning Partners's AGIO Position: Q2 2018 in Review

Avantax Planning Partners sold out of Agios Pharmaceuticals (AGIO) in Q2 2018, closing a stake of 14 shares — an estimated $1K sold.

Avantax Planning Partners first reported a position in AGIO in Q1 2018 and held it in 1 quarter. The position peaked at $1K in Q1 2018. 217 funds tracked by Wall St. Rank hold AGIO as of Q2 2018.

  • Avantax Planning Partners reported no remaining Agios Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • Avantax Planning Partners sold 14 Agios Pharmaceuticals shares in Q2 2018, an estimated $1K.
  • Avantax Planning Partners first reported a position in Agios Pharmaceuticals in Q1 2018 and held it in 1 quarter.
  • Avantax Planning Partners's Agios Pharmaceuticals position peaked at $1K in Q1 2018.
  • 217 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2018.

Based on Avantax Planning Partners's 13F filing for Q2 2018, filed 13 Aug 2018.